- Investigational New Drug (IND) application submitted to the U.S. Food and Drug administration (FDA)
- Plans in place to initiate a Human clinical trial in 60 healthy volunteers in the USA
- Clinical Trial to examine a dosing regimen for Travelan more suited for use by the US military
- Infectious diarrhea is the most common illness reported by travelers
Yum China Leverages Technology To Expand Stores Without Adding More Staff: Report
Yum China Holdings Inc (NYSE: YUMC) is reportedly investing heavily in technology.
According to Yum China's CEO, Joey Wat, the company is increasing its tech investments, enabling it to expand its number of stores without needing additional employees.
